Skip to content
Tel Aviv Sourasky Medical Center
-
Tel Aviv Sourasky Medical Center launches first global clinical trial of Silexion’s KRAS-targeting therapy for pancreatic cancer
The clinical trial will assess SIL204, an investigational treatment developed by Silexion using small interfering RNA (siRNA) technology.